D&T Subcommittee Meeting Bil. 01/2020

posted May 20, 2020, 9:20 PM by Chong Ching Wern   [ updated May 20, 2020, 9:22 PM ]

No.

Drug Name

Decision

1

Anastrozole 1mg Tablet

Agreed to remove Anastrozole 1mg Tablet from Outpatient Pharmacy and maintain Anastrozole as Special Formulary (PharmUMMC Pharmacy only).

Agreed to accept Letrozole 2.5mg Tablet as Standard Formulary (Outpatient Pharmacy only).

2

Apixaban 2.5mg Tablet (Eliquis)

Agreed to add Respiratory Medicine Specialist as prescriber.

3

Apixaban 5 mg Tablet (Eliquis)

Agreed to add Respiratory Medicine Specialist as prescriber.

4

Ciprofloxacin 0.3% Fluocinolone Acetonide 0.025% Ear Drops 

(Cetraxal Plus)

Rejected as Standard Formulary.

Availability of Ofloxacin 0.3% Ear Drop in the UMMC Formulary. Suggest to purchase from retail pharmacies if there is a need to use the combination.

5

Dapagliflozin 10mg Tablet

(Forxiga)

Agreed to add Cardiologist as prescriber.

6

Dupilumab 300mg/2mL Injection

(Dupixent)

Rejected as Special Formulary.

Suggest to apply for use via Borang Ubat Khas (BUK) on a named patient basis.

7

Erenumab 70mg Injection

(Pasurta)

Rejected as Special Formulary.

Suggest to apply for use via Borang Ubat Khas (BUK) on a named patient basis.

8

Escitalopram 10mg Tablet

Agreed to add Neurologist as prescriber.

9

Fondaparinux 7.5mg Injection

(Arixtra)

Rejected as Special Formulary.

There is no additional cost benefit compared to Fondaparinux 2.5mg Injection and Enoxaparin Injection.

10


Fusidic Acid 2% Cream

(Fucidin)


Rejected Fusidic Acid 2% Cream as Standard Formulary.

Availability of Mupirocin 2% Ointment in the UMMC Formulary. Suggest to purchase from retail pharmacies if there is a need to use.

Agreed to add Dermatologist as prescriber for Mupirocin 2% Ointment.

11

Glycopyrronium 50mcg Inhalation Powder Hard Capsule

(Seebri Breezhaler)

Agreed to accept as Special Formulary.

12

Human Normal Immunoglobulin 20% (2g/10mL) Solution for Subcutaneous Injection

(Hizentra)

Agreed to accept as Standard Formulary.

Use is limited to five patients a year.

13

Iron (III) Isomaltoside 500mg/5mL Injection

(Monofer)

Agreed to accept Iron (III) Isomaltoside 500mg/5mL Injection

(Monofer) as Special Formulary.

Agreed to remove Iron Hydroxide Sucrose Complex 100mg/5mL Injection (Venofer) from the UMMC formulary.

14

Ixekizumab 80mg Pre-filled Pen Injection

(Taltz)

Rejected as Special Formulary.

Suggest to apply for use via Borang Ubat Khas (BUK) on a named patient basis.

15

Letrozole 2.5mg Tablet

(Femara)

Agreed to accept Letrozole 2.5mg Tablet as Standard Formulary (Outpatient Pharmacy only).

Agreed to remove Anastrozole 1mg Tablet from Outpatient Pharmacy and maintain Anastrozole 1mg Tablet as Special Formulary (PharmUMMC Pharmacy only).

16


Menotrophin 600units Injection

(Menopur Multidose)


Agreed to accept Menotrophin 600units Injection (Menopur Multidose) as Special Formulary.

Agreed to remove Menotrophin 75units Injection from the UMMC Formulary.

17

Mometasone Furoate Monohydrate 50mcg Nasal Spray

(Momate)

Agreed to accept Mometasone Furoate Monohydrate 50mcg Nasal Spray(Momate) as Standard Formulary.

Agreed to remove Budesonide 64mcg Nasal Spray from the UMMC Formulary.

18

Montelukast 10mg Tablet

Rejected to add Primary Care Specialist as prescriber, to maintain current restriction.

Primary Care Specialists are allowed to continue maintenance treatment initiated by Respiratory Medicine Specialists.

19

Mupirocin 2% Ointment

Agreed to add Dermatologist as prescriber.

20

Salmeterol 25mcg Fluticasone 125mcg Inhaler

Rejected to add Primary Care Specialist as prescriber, to maintain current restriction.

Primary Care Specialists are allowed to continue maintenance treatment initiated by Respiratory Medicine Specialists.

21

Salmeterol 25mcg Fluticasone 250mcg Inhaler

Rejected to add Primary Care Specialist as prescriber, to maintain current restriction.

Primary Care Specialists are allowed to continue maintenance treatment initiated by Respiratory Medicine Specialists.

22

Sirolimus 1mg Tablet

(Rapamune)

To be discussed again in the following D&T Meeting.

23

Venlafaxine 150mg XR Capsule

(Effexor XR)

Agreed to add Neurologist as prescriber.

24

Venlafaxine 37.5mg XR Capsule

(Effexor XR)

Agreed to add Neurologist as prescriber.

25

Venlafaxine 75mg XR Capsule

(Effexor XR)

Agreed to add Neurologist as prescriber.

26

Zonisamide 100mg Tablet

(Zonegran)

Agreed to accept as Standard Formulary.

27

Budesonide 64mcg Nasal Spray

Agreed to remove Budesonide 64mcg Nasal Spray from the UMMC Formulary.

Agreed to accept Mometasone Furoate Monohydrate 50mcg Nasal Spray(Momate) as Standard Formulary.

28

Iron Hydroxide Sucrose Complex 100mg/5mL Injection

(Venofer)

Agreed to remove Iron Hydroxide Sucrose Complex 100mg/5mL Injection (Venofer) from the UMMC formulary.

Agreed to accept Iron (III) Isomaltoside 500mg/5mL Injection

(Monofer) as Special Formulary.

29

Menotrophin 75units Injection

Agreed to remove Menotrophin 75units Injection from the UMMC Formulary.

Agreed to accept Menotrophin 600units Injection (Menopur Multidose) as Special Formulary.



Disclaimer: 

For new drug requests, physical stock availability will depend on procurement processes. 

Tender items will take about 3-6 months, non tender items will take about 1-3 months. 

Online formulary will be updated once physical stock is available or has depleted in UMMC Pharmacy.